EUVIMEDEUVIMED entdecken
Open Access

SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation

Haojie Yan, Qian He, Yubiao Gao, Xiaomei He, Haitao Luo, Lijuan Shao, Jun Dong, Furong Li

International Journal of Oncology · 2025

DOI: 10.3892/ijo.2025.5739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Haojie Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Collaborative Innovation Center, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University; The Firs…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Lactic Acid, Sodium-Bicarbonate Symporters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactate and protein lactylation serve a key role in tumor pathogenesis. Solute carrier 4A7 (SLC4A7), a key transporter, participates in cellular acid homeostasis. However, its impact on lactate transport and protein lactylation in solid tumors, particularly lung adenocarcinoma (LUAD), remains largely unexplored. In the present study, lactylome analysis, Transwell and wound healing assay, animal experiments were conducted to validate functional regulation mediated by SLC4A7 in LUAD. SLC4A7 inhibited tumor progression, including metastasis, invasion and proliferation. Mechanistically, SLC4A7 decreased both intracellular and extracellular lactate accumulation and inhibited overall protein lactylation, as confirmed by lactylome analysis. Analyzing the lactylome revealed that SLC4A7 suppressed lysine lactylation of numerous genes like HSP90AA1 and pathways such as focal adhesion associated with carcinogenesis. Additionally, low expression levels of SLC4A7 in LUAD cancer stem cells were validated using tumor tissue samples from patients with LUAD. Moreover, the inhibitory role of SLC4A7 in regulating tumor stemness was verified. Collectively, the present results uncovered the inhibitory effect exerted by SLC4A7 on tumor progression via its regulation of lactate transport, protein lactylation and stemness properties. Targeting SLC4A7 may hold promise as a novel therapeutic strategy for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAdenocarcinoma of LungLactic AcidSodium-Bicarbonate SymportersHumansAnimalsMiceCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticCarcinogenesisFemaleXenograft Model Antitumor AssaysMaleBiological Transport

Stichwörter der Autor:innen

lactate transportlung adenocarcinomaprotein lactylationsolute carrier 4A7

Substanzen

Lactic AcidSodium-Bicarbonate Symporters

Autor:innen und Institutionen

  • Translational Medicine Collaborative Innovation Center, Shenzhen People's Hospital (The Second Clinical Medical College of Jinan University; The First Affiliated Hospital, Southern University of Science and Technology),…
  • Post‑doctoral Scientific Research Station of Basic Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Zitieren

APA

Yan, H., He, Q., Gao, Y., He, X., Luo, H., Shao, L., Dong, J., & Li, F. (2025). SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation. International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5739

Vancouver

Yan H, He Q, Gao Y, He X, Luo H, Shao L, et al. SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation. International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5739

BibTeX
@article{Yan2025,
  author = {Yan, Haojie and He, Qian and Gao, Yubiao and He, Xiaomei and Luo, Haitao and Shao, Lijuan and Dong, Jun and Li, Furong},
  title = {SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation},
  journal = {International Journal of Oncology},
  year = {2025},
  doi = {10.3892/ijo.2025.5739}
}
Kostenlos starten →